For example, a patient diagnosed with early dementia due to underlying AD may be optimally treated with anti-Aβ DMTs, whereas a patient with early dementia due to SVD may be optimally treated with a potential intervention for SVD such as endothelin antagonists, neurotrophins, or phosphodiesterase inhibitors [30]. Here, BDNF is linked to snowflake vitreoretinal degeneration.